Literature DB >> 31157543

NT-proBNP plasma levels as biomarkers for pulmonary hypertension in healthy infants with respiratory syncytial virus infection.

Moises Rodriguez-Gonzalez1,2, Isabel Benavente-Fernandez2,3, Ana Castellano-Martinez2,4, Alfonso Maria Lechuga-Sancho2,5, Simon Pedro Lubian-Lopez2,3.   

Abstract

Aim: To explore NT-proBNP as biomarker for pulmonary hypertension (PH) in infants with respiratory syncytial virus infection (RSVI). Patients & methods: We prospectively enrolled 93 healthy infants with RSVI aged 1-12 months. NT-proBNP determination and echocardiography were performed at admission.
Results: PH was found in 22% of patients and associated with a severe course of the disease. NT-proBNP >1635 pg/ml resulted an independent predictor for PH (odds ratio: 16.46 [95% CI: 4.10-66; p < 0.001]). The diagnostic performance of NT-proBNP to detect PH in RSVI was high (area under receiver operator curve of 0.932 [95% CI: 0.883-0.981; p < 0.001]). Conclusions: The presence of PH in healthy infants with RSVI is associated with worse outcomes. NT-proBNP resulted an accurate biomarker for PH in this setting.

Entities:  

Keywords:  NT-proBNP; biomarkers; bronchiolitis; cardiopulmonary interactions; echocardiography; hypoxemia; infants; pulmonary hypertension; respiratory acidosis; respiratory syncytial virus

Mesh:

Substances:

Year:  2019        PMID: 31157543     DOI: 10.2217/bmm-2018-0348

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  6 in total

1.  Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension: A meta-analysis.

Authors:  Miaofa Ying; Jin Song; Shenglong Gu; Rui Zhao; Mingxing Li
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

2.  Left Ventricular Dysfunction and Plasmatic NT-proBNP Are Associated with Adverse Evolution in Respiratory Syncytial Virus Bronchiolitis.

Authors:  Moises Rodriguez-Gonzalez; Alvaro Antonio Perez-Reviriego; Ana Castellano-Martinez; Simon Lubian-Lopez; Isabel Benavente-Fernandez
Journal:  Diagnostics (Basel)       Date:  2019-07-27

3.  Cardiovascular impact of COVID-19 with a focus on children: A systematic review.

Authors:  Moises Rodriguez-Gonzalez; Ana Castellano-Martinez; Helena Maria Cascales-Poyatos; Alvaro Antonio Perez-Reviriego
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

4.  Characterization of Cardiopulmonary Interactions and Exploring Their Prognostic Value in Acute Bronchiolitis: A Prospective Cardiopulmonary Ultrasound Study.

Authors:  Moises Rodriguez-Gonzalez; Patricia Rodriguez-Campoy; Ana Estalella-Mendoza; Ana Castellano-Martinez; Jose Carlos Flores-Gonzalez
Journal:  Tomography       Date:  2022-01-05

Review 5.  A narrative review of research advances in hypoxic pulmonary hypertension.

Authors:  Tianci Chai; Chen Qiu; Zhihong Xian; Yongzhen Lu; Yuwei Zeng; Jie Li
Journal:  Ann Transl Med       Date:  2022-02

6.  Deficiency in ST2 signaling ameliorates RSV-associated pulmonary hypertension.

Authors:  Luan D Vu; Jordy Saravia; Sridhar Jaligama; Rajshri V Baboeram Panday; Ryan D Sullivan; Salvatore Mancarella; Stephania A Cormier; Dai Kimura
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-06-25       Impact factor: 5.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.